Excision Medical

Executive Summary

Excision Medical is a privately held medical device company headquartered in Austin, Texas, dedicated to transforming the treatment of structural heart disease through intuitive, precise, and minimally invasive solutions. Founded in 2012, the company focuses on restoring healthy blood flow and improving patient outcomes for individuals with valvular or other structural heart conditions. While specific financial details and pipeline assets are not publicly disclosed, Excision Medical's platform technology is designed to address significant unmet needs in interventional cardiology. The company's approach emphasizes procedural simplicity and enhanced patient recovery, positioning it to compete in the rapidly growing structural heart market. With over a decade of development, Excision Medical is likely nearing key clinical and regulatory milestones, though its private status limits visibility into exact timelines. Given the strong market demand for less invasive heart procedures and the company's focused strategy, Excision Medical represents a promising but early-stage opportunity in cardiovascular innovation.

Upcoming Catalysts (preview)

• Q4 2026FDA Approval for Lead Structural Heart Device60% success
• Q2 2026Pivotal Trial Data Readout for Mitral Valve Repair System50% success
• Q3 2026Strategic Partnership or Licensing Deal with Major Cardiovascular Company70% success